Jun-Ki Min

Title: Jun-Ki Min: Innovator in Pharmaceutical Research

Introduction

Jun-Ki Min, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he has focused on developing compositions that address critical health issues, particularly osteoarthritis and rheumatoid arthritis. His innovative research aims to improve the quality of life for individuals suffering from these conditions.

Latest Patents

Jun-Ki Min's recent patents demonstrate his commitment to advancing medical science. One of his notable inventions is a pharmaceutical composition for the prevention or treatment of osteoarthritis that includes rebamipide as an active ingredient. This composition can be administered orally, typically in a solid dosage form such as tablets or capsules, with dosages ranging from 0.5 to 50 mg/kg, ideally from 0.6 to 6 mg/kg.

In addition, he has developed a similar pharmaceutical composition specifically for the prevention or treatment of rheumatoid arthritis, which also incorporates rebamipide as the primary active component. Like his osteoarthritis formulation, this invention allows for oral administration through a unit dosage form, further highlighting his innovative approach to these prevalent conditions.

Career Highlights

Throughout his career, Jun-Ki Min has worked with reputable organizations that align with his research goals. Notably, he has been associated with Hanlim Pharmaceutical Co., Ltd., where he likely engaged in various pharmaceutical developments. Furthermore, his connection with the Catholic University Academic Cooperation Foundation underscores his commitment to blending academic research with practical applications in the medical field.

Collaborations

Jun-Ki Min has collaborated with notable colleagues, including Mi-La Cho and Yun-Ju Woo, which has undoubtedly enriched his research through diverse perspectives and expertise. These collaborations demonstrate the importance of working with other professionals in driving innovation and advancing scientific discoveries in healthcare.

Conclusion

Jun-Ki Min's contributions to pharmaceutical research reflect his dedication to addressing significant health challenges. With a focus on osteoarthritis and rheumatoid arthritis, his inventions utilizing rebamipide exemplify the potential for innovation to alleviate suffering and improve patient outcomes. As he continues his work, the impact of his research is likely to resonate within the medical community for years to come.